NDC 57894-080 – Lazcluze
Lazertinib 80 mg/1 · Tablet, Film Coated · Oral
Product NDC57894-080
Product details
- Brand name
- Lazcluze
- Generic name
- Lazertinib
- Labeler
- Janssen Biotech, Inc.
- Dosage form
- Tablet, Film Coated
- Route
- Oral
- Marketing category
- NDA · NDA219008
- Marketed since
- August 20, 2024
- Listing expires
- December 31, 2027
- Pharmacologic class
- Kinase Inhibitor
Active ingredients
- Lazertinib 80 mg/1
Package NDC codes (2)
| Package NDC | Description | Since |
|---|---|---|
| 57894-080-60 | 1 BOTTLE in 1 CARTON (57894-080-60) / 60 TABLET, FILM COATED in 1 BOTTLE | Aug 20, 2024 |
| 57894-080-90 | 1 BOTTLE in 1 CARTON (57894-080-90) / 90 TABLET, FILM COATED in 1 BOTTLE | Aug 20, 2024 |
Other Lazcluze products
- 57894-240 Lazertinib 240 mg/1 · Tablet, Film Coated · Janssen Biotech, Inc.